By Josh White
Date: Monday 08 Dec 2025
(Sharecast News) - Proteome Sciences announced on Monday that it has secured a third contract from a US biopharmaceutical client for its mass spectrometry services, further expanding the company's role in supporting clinical development programmes.
| PDMR Dealing | 08-Dec-2025 | 15:15 | RNS |
| Holding(s) in Company | 08-Dec-2025 | 14:31 | RNS |
| Notification of major holdings | 08-Dec-2025 | 13:34 | RNS |
| Holding(s) in Company | 08-Dec-2025 | 12:48 | RNS |
| Directors' / PDMR dealing | 08-Dec-2025 | 12:18 | RNS |
| Questor :GW Pharmaceuticals | 04-Dec-2014 | Telegraph |
| Questor : Hikma Pharmaceuticals | 13-Mar-2014 | Telegraph |
| Investment Column:BTG | 06-Oct-2011 | The Independent |
| Investment Column:Genus | 09-Sep-2011 | The Independent |
| Questor :Dechra Pharmaceuticals | 08-Sep-2011 | Telegraph |
| Price | 25,248.01 |
| Closing Price Change | 12.80 |
| % Change | 0.05 % |
| 08-Dec-25 Close | 25,248.01 |
You are here: research